Revelation Biosciences, Inc.(REVB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

REVB Revelation Biosciences, Inc.

交易中 10-16 14:41:38 EDT

0.4792

-0.2830

-37.13%

最高0.7050	最低0.4700	成交量55.15万
今开0.7050	昨收0.7622	日振幅30.83%
总市值190.88万	流通市值149.83万	总股本398.34万
成交额29.40万	换手率17.64%	流通股本312.67万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"REVB","market":"US","secType":"STK","nameCN":"Revelation Biosciences, Inc.","latestPrice":0.4792,"timestamp":1792176095351,"preClose":0.7622,"halted":0,"volume":551527,"delay":0,"changeRate":-0.37129362372080815,"floatShares":3126650,"shares":3983399,"eps":-12.2877,"marketStatus":"交易中","change":-0.283,"latestTime":"10-16 14:41:38 EDT","open":0.705,"high":0.705,"low":0.47,"amount":294004.61575368,"amplitude":0.308318,"askPrice":0.4792,"askSize":97,"bidPrice":0.4703,"bidSize":11,"shortable":0,"etf":0,"ttmEps":-12.2877,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1792180800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.7622,"preHourTrading":{"tag":"盘前","latestPrice":0.7148,"preClose":0.7622,"latestTime":"09:25 EDT","volume":27703,"amount":19824.4551804,"timestamp":1792157157282,"change":-0.0474,"changeRate":-0.062188,"amplitude":0.179087},"postHourTrading":{"tag":"盘后","latestPrice":0.7622,"preClose":0.7622,"latestTime":"16:50 EDT","volume":4,"amount":3.0765,"timestamp":1792097451137,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":32.034532},"requestUrl":"/m/hq/s/REVB","defaultTab":"news","newsList":[{"id":"1199195455","title":"Revelation Biosciences Inc 第二季度每股收益 -0.87 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1199195455","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199195455?lang=zh_cn&edition=full","pubTime":"2026-08-07 04:38","pubTimestamp":1786048725,"startTime":"0","endTime":"0","summary":"8月6日，Revelation Biosciences, Inc.（REVB）公布第二季度财报。数据显示，该公司净亏损330万美元，每股收益为-0.87美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REVB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518206835","title":"Revelation Biosciences, Inc.盘中异动 下午盘大幅下挫5.44%报3.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518206835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518206835?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:41","pubTimestamp":1741628510,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时41分，Revelation Biosciences, Inc.股票出现波动，股价快速下挫5.44%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。Gemini 是 Revelation 的磷酸化六酰二糖  的专有配方，PHAD 是一种成熟的 TLR4 激动剂，可以刺激人体的先天免疫反应来预防和治疗疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311014150964067e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311014150964067e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVB","REVBU","REVBW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518811592","title":"Revelation Biosciences, Inc.2024财年实现净利润-15.04百万美元，同比减少12406.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518811592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518811592?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536087,"startTime":"0","endTime":"0","summary":"3月10日，Revelation Biosciences, Inc.公布财报，公告显示公司2024财年净利润为-15.04百万美元，同比减少12406.86%；其中营业收入为0.00美元，每股基本收益为-87.68美元。机构评级：截至2025年3月10日，当前有2家机构对Revelation Biosciences, Inc.目标价做出预测，其中目标均价为170.72美元，其中最低目标价为21.45美元，最高目标价为320.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000315a26898a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000315a26898a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","REVB","REVBW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134026864","title":"Revelation生物技术公司第四季度每股收益为$-4.98","url":"https://stock-news.laohu8.com/highlight/detail?id=1134026864","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134026864?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:30","pubTimestamp":1741296640,"startTime":"0","endTime":"0","summary":"Revelation生物技术公司第四季度每股收益为$-4.98以上内容来自Benzinga Earnings专栏，原文如下：Revelation Biosciences Q4 EPS $(4.98)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516603819","title":"Revelation Biosciences, Inc.盘中异动 大幅下挫7.16%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516603819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516603819?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:15","pubTimestamp":1741101319,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时15分，Revelation Biosciences, Inc.股票出现波动，股价大幅下跌7.16%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。Gemini 是 Revelation 的磷酸化六酰二糖  的专有配方，PHAD 是一种成熟的 TLR4 激动剂，可以刺激人体的先天免疫反应来预防和治疗疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231520a25f1216&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231520a25f1216&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","BK4139","REVBW","REVBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516650984","title":"Revelation Biosciences, Inc.盘中异动 快速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516650984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516650984?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:31","pubTimestamp":1741030280,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时31分，Revelation Biosciences, Inc.股票出现异动，股价大幅上涨5.13%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4544.75%、206.64%、181.12%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033121989a51ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033121989a51ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVB","REVBW","REVBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514581376","title":"Revelation Biosciences, Inc.盘中异动 早盘股价大跌5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514581376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514581376?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:36","pubTimestamp":1740756992,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时36分，Revelation Biosciences, Inc.股票出现异动，股价急速下挫5.79%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Bioxcel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1717.03%、413.65%、345.93%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、43.37%、41.62%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282336329896884b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282336329896884b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVB","REVBU","REVBW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514386763","title":"Revelation Biosciences, Inc.盘中异动 早盘快速下跌5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514386763?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:00","pubTimestamp":1740668450,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时00分，Revelation Biosciences, Inc.股票出现波动，股价快速下挫5.55%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。Gemini 是 Revelation 的磷酸化六酰二糖  的专有配方，PHAD 是一种成熟的 TLR4 激动剂，可以刺激人体的先天免疫反应来预防和治疗疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230050abdf767f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230050abdf767f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","REVB","REVBW","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514665016","title":"Revelation Biosciences, Inc.盘中异动 早盘股价大跌6.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514665016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514665016?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:35","pubTimestamp":1740497733,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时35分，Revelation Biosciences, Inc.股票出现异动，股价急速跳水6.70%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1077.24%、598.25%、563.92%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为64.05%、61.16%、60.87%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233533a253965b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233533a253965b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","BK4139","REVB","REVBW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720987","title":"Revelation Biosciences, Inc.盘中异动 股价大跌6.50%报4.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513720987?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:58","pubTimestamp":1740409131,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时58分，Revelation Biosciences, Inc.股票出现波动，股价急速下挫6.50%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。Gemini 是 Revelation 的磷酸化六酰二糖  的专有配方，PHAD 是一种成熟的 TLR4 激动剂，可以刺激人体的先天免疫反应来预防和治疗疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225851962e9f98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225851962e9f98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","REVBU","BK4139","REVBW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512161262","title":"Revelation Biosciences, Inc.盘中异动 早盘急速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512161262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512161262?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:37","pubTimestamp":1739893024,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时37分，Revelation Biosciences, Inc.股票出现异动，股价大幅拉升5.14%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为366.61%、162.38%、138.79%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233704a24abbd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233704a24abbd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","BK4139","REVB","REVBW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511069139","title":"Revelation Biosciences, Inc.盘中异动 股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511069139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511069139?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:59","pubTimestamp":1739545142,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时59分，Revelation Biosciences, Inc.股票出现波动，股价大幅上涨5.53%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2109.24%、541.49%、445.01%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、40.35%、33.28%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225902abcf0ce0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214225902abcf0ce0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","REVBU","BK4139","REVBW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510805703","title":"Revelation Biosciences, Inc.盘中异动 急速下挫6.58%报3.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510805703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510805703?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:36","pubTimestamp":1739284613,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时36分，Revelation Biosciences, Inc.股票出现波动，股价大幅跳水6.58%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2118.25%、551.67%、199.07%，振幅较大的相关个股有In8Bio, Inc.、Dominari Holdings Inc.、Ocean Biomedical, Inc.，振幅分别为31.80%、25.49%、22.23%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223654a241fc5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223654a241fc5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVBU","REVBW","REVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510865395","title":"Revelation Biosciences, Inc.盘中异动 股价大跌5.11%报3.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510865395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510865395?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:35","pubTimestamp":1739198111,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时35分，Revelation Biosciences, Inc.股票出现波动，股价大幅下跌5.11%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.、Dominari Holdings Inc.涨幅较大，Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为946.71%、622.76%、259.26%，振幅较大的相关个股有Soligenix, Inc.、Tyra Biosciences, Inc.、Invivyd, Inc.，振幅分别为103.16%、100.83%、29.90%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223511abc9a634&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223511abc9a634&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","BK4139","REVBW","REVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509729975","title":"Revelation Biosciences, Inc.盘中异动 股价大跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509729975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509729975?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:49","pubTimestamp":1738946958,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时49分，Revelation Biosciences, Inc.股票出现异动，股价大幅下跌5.85%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。Gemini 是 Revelation 的磷酸化六酰二糖  的专有配方，PHAD 是一种成熟的 TLR4 激动剂，可以刺激人体的先天免疫反应来预防和治疗疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208004918abc648fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208004918abc648fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","BK4139","REVB","REVBW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509516258","title":"Revelation Biosciences, Inc.盘中异动 下午盘股价大跌5.83%报4.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509516258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509516258?lang=zh_cn&edition=full","pubTime":"2025-02-06 03:21","pubTimestamp":1738783300,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日03时21分，Revelation Biosciences, Inc.股票出现异动，股价急速下挫5.83%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为2.30%。其相关个股中，Invivyd, Inc.、Transcode Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4627.17%、2344.35%、1750.17%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Invivyd, Inc.，振幅分别为132.24%、99.51%、67.19%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502060321409619365f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502060321409619365f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","BK4139","REVBW","REVBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508127774","title":"Revelation Biosciences, Inc.盘中异动 股价大涨7.66%报4.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508127774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508127774?lang=zh_cn&edition=full","pubTime":"2025-02-04 04:11","pubTimestamp":1738613472,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日04时11分，Revelation Biosciences, Inc.股票出现波动，股价急速上涨7.66%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Invivyd, Inc.、Hcw Biologics Inc.、Gh Research Plc涨幅较大，Cyclerion Therapeutics, Inc.、Hcw Biologics Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为1020.73%、744.81%、474.24%，振幅较大的相关个股有Invivyd, Inc.、Hcw Biologics Inc.、Briacell Therapeutics Corp.，振幅分别为171.29%、170.13%、63.94%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204041112abc14ba6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204041112abc14ba6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBU","BK4139","REVB","REVBW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507665969","title":"Revelation Biosciences, Inc.盘中异动 早盘大幅上涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507665969","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507665969?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:45","pubTimestamp":1738334729,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时45分，Revelation Biosciences, Inc.股票出现异动，股价急速上涨5.44%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为1574.16%、590.60%、80.88%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nutriband Inc C/Wts ，振幅分别为63.20%、43.70%、42.27%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131224529abbe3e59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131224529abbe3e59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","REVB","REVBU","REVBW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507621916","title":"Revelation Biosciences, Inc.盘中异动 早盘股价大跌6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507621916?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:34","pubTimestamp":1738247670,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时34分，Revelation Biosciences, Inc.股票出现异动，股价大幅跳水6.45%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。Gemini 是 Revelation 的磷酸化六酰二糖  的专有配方，PHAD 是一种成熟的 TLR4 激动剂，可以刺激人体的先天免疫反应来预防和治疗疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223430a23455cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223430a23455cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVB","REVBW","REVBU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507365823","title":"Revelation Biosciences, Inc.盘中异动 股价大涨6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507365823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507365823?lang=zh_cn&edition=full","pubTime":"2025-01-29 23:16","pubTimestamp":1738163762,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日23时16分，Revelation Biosciences, Inc.股票出现波动，股价快速拉升6.13%。Revelation Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Revelation Biosciences, Inc.公司简介：Revelation Biosciences Inc 是一家临床阶段的生命科学公司，专注于开发利用训练免疫来预防和治疗疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012923160296139ba9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012923160296139ba9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["REVBW","REVBU","BK4139","REVB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revbiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0151},{"period":"1month","weight":-0.1628},{"period":"3month","weight":-0.3541},{"period":"6month","weight":-0.3343},{"period":"1year","weight":-0.8599},{"period":"ytd","weight":-0.7618}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.019},{"period":"3month","weight":0.0383},{"period":"6month","weight":0.0868},{"period":"1year","weight":0.1603},{"period":"ytd","weight":0.1318}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revelation Biosciences, Inc.是一家特拉华州公司，成立于2019年11月20日。该公司是一家临床阶段的生命科学公司，专注于开发用于预防和治疗疾病的免疫疗法。Revelation有几个正在开发的候选产品。REVTx-99是主要的治疗候选药物，是一种鼻内免疫调节剂，用于预防或治疗由各种呼吸道病毒引起的感染。REVTx-99也正在开发用于其他适应症，例如：过敏性鼻炎和慢性鼻塞。REVTx-200是一种鼻内免疫调节剂辅助剂，可与肌肉注射疫苗联合使用，以获得更完全的免疫。Revelation还在开发REVDx-501，这是一种快速的家用诊断工具，可用于检测任何呼吸道病毒感染，无需专门的仪器。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.239557},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.378347},{"month":3,"riseRate":0,"avgChangeRate":-0.190888},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.076574},{"month":5,"riseRate":0,"avgChangeRate":-0.219406},{"month":6,"riseRate":0.333333,"avgChangeRate":0.137625},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.121737},{"month":8,"riseRate":0.5,"avgChangeRate":-0.101758},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.207384},{"month":10,"riseRate":0.5,"avgChangeRate":-0.034683},{"month":11,"riseRate":0.4,"avgChangeRate":-0.088914},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.150121}],"exchange":"NASDAQ","name":"Revelation Biosciences, Inc.","nameEN":"Revelation Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revelation Biosciences, Inc.(REVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Revelation Biosciences, Inc.(REVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Revelation Biosciences, Inc.,REVB,Revelation Biosciences, Inc.股票,Revelation Biosciences, Inc.股票老虎,Revelation Biosciences, Inc.股票老虎国际,Revelation Biosciences, Inc.行情,Revelation Biosciences, Inc.股票行情,Revelation Biosciences, Inc.股价,Revelation Biosciences, Inc.股市,Revelation Biosciences, Inc.股票价格,Revelation Biosciences, Inc.股票交易,Revelation Biosciences, Inc.股票购买,Revelation Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revelation Biosciences, Inc.(REVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Revelation Biosciences, Inc.(REVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}